Method for treatment of anxiety
AssigneeHoward Florey Institute of Experimental Physiology and Medicine
InventorsGeoffrey Tregear, Ross Alexander David Bathgate, Chrishan Surendran Samuel, Tanya Christine Burazin, Andrew Lawrence Gundlach, John Desmond Wade
Life of this patent
Estimating the term…
Abstract
Human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, human relaxin analogues having a modified A chain and/or a modified B chain are described. Also described are nucleic acid sequences encoded human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, human relaxin analogues. Also described are methods for the treatment of conditions responsive to administration of H3 relaxin or analogues thereof.
Claims7
A method for treatment of anxiety which comprising administering to a subject suffering from anxiety a therapeutically effective amount of human H3 relaxin, optionally in association with one or more pharmaceutically acceptable carriers and/or diluents and/or excipients, wherein the H3 relaxin comprises an A chain which comprises the amino acid sequence shown in SEQ ID NO:45.
A method for treatment of anxiety comprising administering to a subject suffering from anxiety a therapeutically effective amount of an analogue of human H3 relaxin, optionally in association with one or more pharmaceutically acceptable carriers and/or diluents and/or excipients, wherein the analogue of H3 relaxin comprises an A chain which comprises an amino acid sequence that is at least 95% identical the amino acid sequence shown in SEQ ID NO:45.
Dependencies are inferred from the claim text.